Home β€Ί Stock analysis β€Ί RDNT

RadNet (RDNT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

RDNT dips 2.3% to $68.80. Closed at $68.80, -2.29% vs the prior close of $70.41. Day range $68.51–$70.43, opened at $70.41.

Last close$68.80-2.29%
Day range68.51–70.43
Open70.41
Volume385.88K
52-week range50.82–85.84
Avg volume (20d)572.30K

RDNT daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” RDNT dips 2.3% to $68.80
Oct 15, 2026 β€” RDNT rises 1.8% to $70.41
Oct 14, 2026 β€” RDNT slides 3.3% to $69.16
Oct 13, 2026 β€” RDNT ends flat (+0.0%) to $71.51, 3 up days in a row
Oct 12, 2026 β€” RDNT rises 0.8% to $71.49
Oct 9, 2026 β€” RDNT jumps 4.0% to $70.91
Oct 8, 2026 β€” RDNT dips 0.6% to $68.21, 3 down days in a row
Oct 7, 2026 β€” RDNT dips 2.4% to $68.61
Oct 6, 2026 β€” RDNT dips 0.4% to $70.28
Oct 5, 2026 β€” RDNT rises 0.9% to $70.57
Oct 2, 2026 β€” RDNT jumps 3.3% to $69.93

RDNT latest news & SEC filings

Every SEC filing by or about RDNT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Aug 14, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001683168-26-006479

Aug 14, 2026 Β· Form 424B7 β€” Prospectus supplement for a resale by holders

Prospectus supplement for a resale by holders

An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.

Source: SEC EDGAR filing 0001683168-26-006476

Aug 14, 2026 Β· Form SCHEDULE 13G/A β€” Update to a passive 5%+ stake (13G)

Update to a passive 5%+ stake (13G)

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001493215-26-000155

Aug 10, 2026 Β· Form 10-Q β€” Quarterly report

Quarterly report (unaudited financial statements for the quarter)

Quarter ended Jun 30, 2026:

Source: SEC EDGAR filing 0001628280-26-055338

Aug 10, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

This is a results-day filing: the earnings press release is attached as an exhibit.

Source: SEC EDGAR filing 0001683168-26-006125

Jun 22, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001683168-26-005022

Things to know before you trade RDNT

RDNT market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 202670.4170.4368.5168.80385.88K
Oct 15, 202670.1270.8269.0770.41461.20K
Oct 14, 202670.6571.9069.0269.16477.70K
Oct 13, 202670.8172.1570.0071.51478.00K
Oct 12, 202670.8871.7870.1171.49383.40K
Oct 9, 202668.4171.1168.1370.91507.40K
Oct 8, 202668.1668.5066.2368.21722.30K
Oct 7, 202669.5770.6668.4568.61398.60K
Oct 6, 202671.2771.5469.4470.28291.70K
Oct 5, 202669.8771.8669.4070.57681.40K
Oct 2, 202668.5270.6867.8069.93574.20K
Oct 1, 202668.8069.7067.3267.70928.70K
Sep 30, 202670.2270.8568.9468.94621.20K
Sep 29, 202671.9272.5869.4970.65501.00K
Sep 28, 202670.0872.8469.6271.81528.20K
Sep 25, 202670.8171.4869.5870.79598.70K
Sep 24, 202673.1173.7070.9671.31754.10K
Sep 23, 202673.6174.3572.6873.21560.70K
Sep 22, 202673.7174.8173.0173.93795.40K
Sep 21, 202676.2776.4572.6272.67796.20K

About RadNet

RadNet (RDNT) is listed on the Nasdaq and classified by the SEC under β€œServices-Medical Laboratories”. Its business address is in LOS ANGELES, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 790526.

RDNT board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Howard G BergerPresident, CEOJun 18, 2026
Laura Pastre JacobsDirectorJun 3, 2026
Lawrence L LevittDirectorJun 3, 2026
Gregory E. SpurlockDirectorJun 3, 2026
David L SwartzDirectorJun 22, 2026
Alma Gregory SorensenChief Strategy OfficerMar 23, 2026

Executive officers

NameTitleLatest filing
Howard G BergerPresident, CEOJun 18, 2026
Stephen M ForthuberPres & CEO-Eastern OperationsJun 16, 2026
Norman R HamesPres and COO-West OperationsMar 5, 2026
David Jeffrey KatzEVP and Chief Legal OfficerMar 5, 2026
Michael N MurdockEVP, Mergers and AcquisitionsMar 5, 2026
Mital PatelEVP of Fin Planning, CAOMar 5, 2026
Mark StolperEVP, Chief Financial OfficerMar 5, 2026
Alma Gregory SorensenChief Strategy OfficerMar 23, 2026
Cornelis WesdorpPres & CEO, Digital HealthJun 18, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
Jun 18, 2026David L SwartzSale2,699$53.89
Jun 18, 2026David L SwartzSale2,699$53.89
Jun 18, 2026David L SwartzSale2,699$53.89
Jun 18, 2026David L SwartzSale2,699$53.89
Jun 16, 2026Cornelis WesdorpSale4,750$58.11
Jun 16, 2026Cornelis WesdorpSale4,750$58.11
Jun 16, 2026Cornelis WesdorpSale4,750$58.11
Jun 16, 2026Cornelis WesdorpSale4,750$58.11
Jun 15, 2026Stephen M ForthuberSale19,853$58.61
Jun 15, 2026Stephen M ForthuberSale24,214$57.79
Jun 15, 2026Stephen M ForthuberSale19,853$58.61
Jun 15, 2026Stephen M ForthuberSale24,214$57.79
Jun 15, 2026Stephen M ForthuberSale19,853$58.61
Jun 15, 2026Stephen M ForthuberSale24,214$57.79
Jun 15, 2026Stephen M ForthuberSale19,853$58.61

RDNT financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025$2.04B$-18.65M-0.25$298.82M
Dec 31, 2024$1.83B$2.79M0.04$233.02M
Dec 31, 2023$1.62B$3.04M0.05$220.86M
Dec 31, 2022$1.43B$10.65M0.17$146.42M
Dec 31, 2021$1.32B$24.73M0.46$149.49M

Latest balance sheet: total assets $4.23B, total liabilities $2.83B, cash $726.27M (as of Jun 30, 2026).

RDNT earnings / results-day log

DateFilingClose that day
Aug 10, 20268-K Item 2.02 (results)$77.28
May 11, 20268-K Item 2.02 (results)$55.90
Mar 2, 20268-K Item 2.02 (results)$75.22
Nov 10, 20258-K Item 2.02 (results)$80.85
Aug 11, 20258-K Item 2.02 (results)$62.00
May 12, 20258-K Item 2.02 (results)$57.03
Mar 5, 20258-K Item 2.02 (results)$53.09
Nov 12, 20248-K Item 2.02 (results)$83.59
Aug 9, 20248-K Item 2.02 (results)β€”
May 13, 20248-K Item 2.02 (results)β€”
Mar 5, 20248-K Item 2.02 (results)β€”
Nov 13, 20238-K Item 2.02 (results)β€”

Related stocks Β· Services-Medical Laboratories

Natera (NTRA)Guardant Health (GH)Quest Diagnostics (DGX)Labcorp (LH)Grail (GRAL)Caris Life Sciences (CAI)Celcuity (CELC)CareDx (CDNA)Veracyte (VCYT)BillionToOne (BLLN)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on RDNT

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.